HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Supplemental Data All Versions of this Article: T500019-MCP200v1 5/1/26    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Glossary Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sheng, S. Articles by Van Eyk, J. E. Search for Related Content PubMed PubMed Citation Articles by Sheng, S. Articles by Van Eyk, J. E. Social Bookmarking                      What's this?

Molecular & Cellular Proteomics 5:26-34, 2006.
© 2006 by The American Society for Biochemistry and Molecular Biology, Inc.

---

Technology

Multidimensional Liquid Chromatography Separation of Intact Proteins by Chromatographic Focusing and Reversed Phase of the Human Serum Proteome

Optimization and Protein Database^*,S

Simon Sheng, Dawn Chen^,¶ and Jennifer E. Van Eyk^,,||,**

From the Departments of Medicine, Biological Chemistry, and ^|| Biomedical Engineering and ^¶ The Technical Implementation and Coordination Core of NHLBI Proteomics Center, The Johns Hopkins University, Baltimore, Maryland 21224

In biomarker discovery, the detection of proteins with low abundance in the serum proteome can be achieved by optimization of protein separation methods as well as selective depletion of the higher abundance proteins such as immunoglobins (e.g. IgG) and albumin. A relative newcomer to the proteomic separation arena is the commercial instrument PF2D from Beckman Coulter that separates proteins in the first dimension using chromatofocusing followed in line by reversed phase chromatography in the second dimension, thereby separating intact proteins based on pI and hydrophobicity. In this study, assessment and optimization of serum separation (undepleted serum and albumin-IgG-depleted serum) by the PF2D is presented. Protein databases were created for serum obtained from a healthy individual under traditional and optimized methods and under different sample preparation protocols. Separation of the doubly depleted serum using the PF2D with 20% isopropanol present in the first dimension running buffer allowed us to unambiguously identify 150 non-redundant serum proteins (excluding all immunoglobulin and albumin, a minimum of two peptide matches with acceptable Mascot score) in which 81 have not been identified previously in serum. Among them, numerous cellular proteins were identified to be specifically the skeletal muscle isoform, such as skeletal muscle fast twitch isoforms of troponin T, myosin alkali light chain 1, and sarcoplasmic/endoplasmic reticulum calcium ATPase. The detection of specific skeletal muscle protein isoforms in the serum from healthy individuals reflects the physiological turnover that occurs in skeletal muscle, which will have an impact on the ability to use generic "cellular" proteins as biomarkers without further characterization of the precise isoforms or post-translational modifications present.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				P. Matt, Z. Fu, Q. Fu, and J. E. Van Eyk Biomarker discovery: proteome fractionation and separation in biological samples Physiol Genomics, March 10, 2008; 33(1): 12 - 17. [Abstract] [Full Text] [PDF]

				Y. Guo, Z. Fu, and J. E. Van Eyk A Proteomic Primer for the Clinician Proceedings of the ATS, January 1, 2007; 4(1): 9 - 17. [Abstract] [Full Text] [PDF]

				T. McDonald, S. Sheng, B. Stanley, D. Chen, Y. Ko, R. N. Cole, P. Pedersen, and J. E. Van Eyk Expanding the Subproteome of the Inner Mitochondria Using Protein Separation Technologies: One- and Two-dimensional Liquid Chromatography and Two-dimensional Gel Electrophoresis Mol. Cell. Proteomics, December 1, 2006; 5(12): 2392 - 2411. [Abstract] [Full Text] [PDF]

				T. Liu, W.-J. Qian, M. A. Gritsenko, W. Xiao, L. L. Moldawer, A. Kaushal, M. E. Monroe, S. M. Varnum, R. J. Moore, S. O. Purvine, et al. High Dynamic Range Characterization of the Trauma Patient Plasma Proteome Mol. Cell. Proteomics, October 1, 2006; 5(10): 1899 - 1913. [Abstract] [Full Text] [PDF]

				W.-J. Qian, J. M. Jacobs, T. Liu, D. G. Camp II, and R. D. Smith Advances and Challenges in Liquid Chromatography-Mass Spectrometry-based Proteomics Profiling for Clinical Applications Mol. Cell. Proteomics, October 1, 2006; 5(10): 1727 - 1744. [Abstract] [Full Text] [PDF]

				A. V. Gomes, C. Zong, R. D. Edmondson, X. Li, E. Stefani, J. Zhang, R. C. Jones, S. Thyparambil, G.-W. Wang, X. Qiao, et al. Mapping the Murine Cardiac 26S Proteasome Complexes Circ. Res., August 18, 2006; 99(4): 362 - 371. [Abstract] [Full Text] [PDF]

				G. L. Hortin, S. A. Jortani, J. C. Ritchie Jr, R. Valdes Jr, and D. W. Chan Proteomics: A New Diagnostic Frontier Clin. Chem., July 1, 2006; 52(7): 1218 - 1222. [Abstract] [Full Text] [PDF]